TNFRSF10B and neoplasm: If DR5 agonist stabilize PD‐L1 via proteasome inactivation, we hypothesized significantly higher degradation of proteasome regulatory submits in DR5‐WT tumor cell lines as compared to DR5‐KO cells upon DR5 agonist treatments.